Hashim Mumtaz, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 S Oakwood Rd, Oshkosh, WI 54904 Phone: 920-223-2000 Fax: 920-223-1230 |
Raul R Garcia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 S Oakwood Rd, Oshkosh, WI 54904 Phone: 920-223-2300 |
Dr. Kingston Okrah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2700 W 9th Ave, Ste. 310, Oshkosh, WI 54904 Phone: 920-223-3550 |
Abdulmajid Adam, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 862-218-4482 |
Dr. James Bruno, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 135 Jackson St, Oshkosh, WI 54901 Phone: 920-303-8100 Fax: 920-303-8100 |
Indira Pulakandum, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 500 S Oakwood Rd, Oshkosh, WI 54904 Phone: 920-223-2000 |
Jyot M Soni, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 |
Dr. Asma Sabih, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-6000 Fax: 920-303-5630 |
News Archive
In recent years, American hospitals have made significant improvements on standardized, evidence-based measures of clinical performance for several medical conditions, including heart attacks, heart failure, and pneumonia.
One of the most obvious changes that comes with aging is that people start doing things more slowly. Numerous studies have shown that aging also affects language processing.
A study published in the peer reviewed Journal of Translational Medicine demonstrated administration of Stem-Kine, a commercially available nutritional supplement, significantly elevated levels of two types of stem cells in circulation.
ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque and first author of the abstract, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)," (Abstract #10004) presented in an oral session today updated positive data from PICASSO.
Scientists at the University of Bonn, together with colleagues from the USA and Japan, have shed light on an important immune mechanism. Their work shows how the body provides the important killer cells with a helper in the case of an infection. The study could point the way to better vaccines in the future.
› Verified 9 days ago